Burden of copy number alterations predicts outcomes in immune checkpoint blockade treated gastrointestinal cancer patients

被引：0
|
作者：
Lu, Zhihao
Chen, Huan
Li, Shuang
Jiao, Xi
Wu, Lihong
Zhang, Henghui
Shen, Lin
机构：
[1] Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Beijing, Peoples R China
[2] Genecast Precis Med Technol Inst, Beijing, Peoples R China
[3] Beijing Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14068
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A RNA signature predicts outcomes in immune checkpoint blockade treated gastrointestinal cancer patients.
    Lu, Zhihao
    Chen, Huan
    Li, Shuang
    Jiao, Xi
    Wu, Lihong
    Yu, Jianing
    Shen, Lin
    Zhang, Henghui
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer
    Lu, Zhihao
    Chen, Huan
    Li, Shuang
    Gong, Jifang
    Li, Jian
    Zou, Jianling
    Wu, Lihong
    Yu, Jianing
    Han, Wenbo
    Sun, Huaibo
    Jiao, Xi
    Zhang, Xiaotian
    Peng, Zhi
    Lu, Ming
    Wang, Zhenghang
    Zhang, Henghui
    Shen, Lin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [3] Tumor Copy Number Alteration Burden as a Predictor for Resistance to Immune Checkpoint Blockade across Different Cancer Types
    Asleh, Karama
    Ouellette, Rodney J.
    CANCERS, 2024, 16 (04)
  • [4] Copy number alteration burden predicts prostate cancer relapse
    Hieronymus, Haley
    Schultz, Nikolaus
    Gopalan, Anuradha
    Carver, Brett S.
    Chang, Matthew T.
    Xiao, Yonghong
    Heguy, Adriana
    Huberman, Kety
    Bernstein, Melanie
    Assel, Melissa
    Murali, Rajmohan
    Vickers, Andrew
    Scardino, Peter T.
    Sander, Chris
    Reuter, Victor
    Taylor, Barry S.
    Sawyers, Charles L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (30) : 11139 - 11144
  • [5] Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
    Yujiao Wang
    Xi Jiao
    Shuang Li
    Huan Chen
    Xin Wei
    Chang Liu
    Jifang Gong
    Xiaotian Zhang
    Xicheng Wang
    Zhi Peng
    Changsong Qi
    Zhenghang Wang
    Yanni Wang
    Na Zhuo
    Jianling Zou
    Henghui Zhang
    Jian Li
    Lin Shen
    Zhihao Lu
    Cancer Biology & Medicine, 2022, 19 (08) : 1139 - 1149
  • [6] Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
    Wang, Yujiao
    Jiao, Xi
    Li, Shuang
    Chen, Huan
    Wei, Xin
    Liu, Chang
    Gong, Jifang
    Zhang, Xiaotian
    Wang, Xicheng
    Peng, Zhi
    Qi, Changsong
    Wang, Zhenghang
    Wang, Yanni
    Zhuo, Na
    Zou, Jianling
    Zhang, Henghui
    Li, Jian
    Shen, Lin
    Lu, Zhihao
    CANCER BIOLOGY & MEDICINE, 2022, 19 (08) : 1139 - 1149
  • [7] Derivation and characterization of antibodies from immune checkpoint blockade treated cancer patients
    Branum, Mark
    Smith, Laura
    Brett, Heather
    Algate, Paul
    Greenfield, Brad
    Brown, William
    Swiderek, Kristine M.
    CANCER RESEARCH, 2016, 76
  • [8] A genomic signature for accurate classification and prediction of clinical outcomes in cancer patients treated with immune checkpoint blockade immunotherapy
    Mei Lu
    Kuan-Han Hank Wu
    Sheri Trudeau
    Margaret Jiang
    Joe Zhao
    Elliott Fan
    Scientific Reports, 10
  • [9] A genomic signature for accurate classification and prediction of clinical outcomes in cancer patients treated with immune checkpoint blockade immunotherapy
    Lu, Mei
    Wu, Kuan-Han Hank
    Trudeau, Sheri
    Jiang, Margaret
    Zhao, Joe
    Fan, Elliott
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [10] Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma
    Bolte, Laura A.
    Lee, Karla A.
    Bjork, Johannes R.
    Leeming, Emily R.
    Campmans-Kuijpers, Marjo J. E.
    de Haan, Jacco J.
    Vila, Arnau Vich
    Maltez-Thomas, Andrew
    Segata, Nicola
    Board, Ruth
    Harries, Mark
    Lorigan, Paul
    de Vries, Elisabeth G. E.
    Nathan, Paul
    Fehrmann, Rudolf
    Bataille, Veronique
    Spector, Tim D.
    Hospers, Geke A. P.
    Weersma, Rinse K.
    JAMA ONCOLOGY, 2023, 9 (05) : 705 - 709
12345